+1803294983432
customer.service@microbix.com
COVID-19 Blog
Microbix Presenting at Cantech Investment Conference
Meetings with Growth-Oriented Investors, October 8, 2026 MISSISSAUGA, CANADA, October 6, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX:…
Microbix Presenting at Muskoka Capital Event
Meetings with Growth-Oriented Investors, September 25 to 27, 2026 MISSISSAUGA, CANADA, September 23, 2026 – Microbix Biosystems…
Microbix Qualifies as Supplier for Five Major Dx Test-Makers
Product Lines for Support of Leading IVD Manufacturers MISSISSAUGA, CANADA, April 27, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX:…
Microbix Reports Results for Q3 Fiscal 2026
Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, CANADA, August 13, 2026 – Microbix Biosystems Inc. (TSX: MBX,…
Microbix Schedules Release of Results for Q3 Fiscal 2026
Microbix Schedules Release of Results for Q3 Fiscal 2026 Results Release and Webinar Discussion on Morning of August 13, 2026…
Episode 9: Diagnostics Beyond the Lab: Closing the Gap
09
Microbix Reports Results for H1 & Q2 2026
H1 Revenues of $7.6 million and Controlled Net Loss MISSISSAUGA, CANADA, May 14, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX:…
Episode 8: Diagnostics Beyond the Lab: Can You Trust Your Test?
08
Microbix Schedules Release of Results for Q2 Fiscal 2026
Microbix announces announces it will be attending and presenting at the 2026 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on April 21 and 22, 2026.
Microbix Product Results Being Presented at 2026 PASCV
Microbix announces announces it will be attending and presenting at the 2026 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on April 21 and 22, 2026.
